Skip to main content
main-content
Erschienen in: Die Chirurgie 6/2019

07.05.2019 | Rektumkarzinom | Kommentar

Transanale totale mesorektale Exzision

Eine sinnvolle Komplementärmethode zur minimal-invasiven Operation des Rektumkarzinoms

verfasst von: PD Dr. A. D. Rink, F. Aigner, M. Biebl, A. Fürst, W. Kneist

Erschienen in: Die Chirurgie | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Auszug

Holmer C, Benz S, Fichtner-Feigl S et al (2019) Transanale totale mesorektale Exzision – eine kritische Standortbestimmung. Chirurg (EPub ahead of print) https://​doi.​org/​10.​1007/​s00104-019-0945-x
Literatur
1.
Zurück zum Zitat Persiani R, Biondi A, Pennestri F, Fico V, De Simone V, Tirelli F et al (2018) Transanal Total Mesorectal Excision vs Laparoscopic Total Mesorectal Excision in the Treatment of Low and Middle Rectal Cancer: A Propensity Score Matching Analysis. Dis Colon Rectum 61(7):809–816 PubMed Persiani R, Biondi A, Pennestri F, Fico V, De Simone V, Tirelli F et al (2018) Transanal Total Mesorectal Excision vs Laparoscopic Total Mesorectal Excision in the Treatment of Low and Middle Rectal Cancer: A Propensity Score Matching Analysis. Dis Colon Rectum 61(7):809–816 PubMed
2.
Zurück zum Zitat Perdawood SK, Thinggaard BS, Bjoern MX (2018) Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term outcomes with laparoscopic and open surgeries. Surg Endosc 32(5):2312–2321 CrossRefPubMed Perdawood SK, Thinggaard BS, Bjoern MX (2018) Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term outcomes with laparoscopic and open surgeries. Surg Endosc 32(5):2312–2321 CrossRefPubMed
3.
Zurück zum Zitat Lelong B, Meillat H, Zemmour C, Poizat F, Ewald J, Mege D et al (2017) Short- and Mid-Term Outcomes after Endoscopic Transanal or Laparoscopic Transabdominal Total Mesorectal Excision for Low Rectal Cancer: A Single Institutional Case-Control Study. J Am Coll Surg 224(5):917–925 CrossRefPubMed Lelong B, Meillat H, Zemmour C, Poizat F, Ewald J, Mege D et al (2017) Short- and Mid-Term Outcomes after Endoscopic Transanal or Laparoscopic Transabdominal Total Mesorectal Excision for Low Rectal Cancer: A Single Institutional Case-Control Study. J Am Coll Surg 224(5):917–925 CrossRefPubMed
4.
Zurück zum Zitat van der Pas MH, Haglind E, Cuesta MA, Furst A, Lacy AM, Hop WC et al (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 14(3):210–218 CrossRefPubMed van der Pas MH, Haglind E, Cuesta MA, Furst A, Lacy AM, Hop WC et al (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 14(3):210–218 CrossRefPubMed
5.
Zurück zum Zitat Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ et al (2015) Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial. JAMA 314(13):1356–1363 CrossRefPubMed Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ et al (2015) Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial. JAMA 314(13):1356–1363 CrossRefPubMed
6.
Zurück zum Zitat Kreis ME, Ruppert R, Ptok H, Strassburg J, Brosi P, Lewin A, et al (2016) Use of preoperative magnetic resonance imaging to select patients with rectal cancer for neoadjuvant chemoradiation—interim analysis of the German OCUM trial (NCT01325649). J Gastrointest Surg 20(1):25–32 CrossRefPubMed Kreis ME, Ruppert R, Ptok H, Strassburg J, Brosi P, Lewin A, et al (2016) Use of preoperative magnetic resonance imaging to select patients with rectal cancer for neoadjuvant chemoradiation—interim analysis of the German OCUM trial (NCT01325649). J Gastrointest Surg 20(1):25–32 CrossRefPubMed
7.
Zurück zum Zitat Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M et al (2015) Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. JAMA 314(13):1346–1355 CrossRefPubMedPubMedCentral Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M et al (2015) Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. JAMA 314(13):1346–1355 CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Spinelli A D’Hoore A, Panis Y, Bemelman WA, Jayne DG, Fürst A (2017) A critical appraisal of two randomized clinical trials on pathologic outcomes. Coloproctology 39(4):277 CrossRef Spinelli A D’Hoore A, Panis Y, Bemelman WA, Jayne DG, Fürst A (2017) A critical appraisal of two randomized clinical trials on pathologic outcomes. Coloproctology 39(4):277 CrossRef
9.
Zurück zum Zitat Bondeven P, Hagemann-Madsen RH, Laurberg S, Pedersen BG (2013) Extent and completeness of mesorectal excision evaluated by postoperative magnetic resonance imaging. Br J Surg 100(10):1357–1367 CrossRefPubMed Bondeven P, Hagemann-Madsen RH, Laurberg S, Pedersen BG (2013) Extent and completeness of mesorectal excision evaluated by postoperative magnetic resonance imaging. Br J Surg 100(10):1357–1367 CrossRefPubMed
10.
Zurück zum Zitat Veltcamp Helbach M, Koedam TWA, Knol JJ, Diederik A, Spaargaren GJ, Bonjer HJ et al (2019) Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer. Surg Endosc 33(1):94–102 CrossRefPubMed Veltcamp Helbach M, Koedam TWA, Knol JJ, Diederik A, Spaargaren GJ, Bonjer HJ et al (2019) Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer. Surg Endosc 33(1):94–102 CrossRefPubMed
11.
Zurück zum Zitat Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J et al (2017) Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial. JAMA 318(16):1569–1580 CrossRefPubMedPubMedCentral Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J et al (2017) Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial. JAMA 318(16):1569–1580 CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Rink AD, Kauff DW, Paschold M, Vestweber KH, Lang H, Kneist W (2016) Hybrid TAMIS total mesorectal excision. A new perspective in treatment of distal rectal cancer—Technique and results. Chirurg 87(3):225–232 CrossRefPubMed Rink AD, Kauff DW, Paschold M, Vestweber KH, Lang H, Kneist W (2016) Hybrid TAMIS total mesorectal excision. A new perspective in treatment of distal rectal cancer—Technique and results. Chirurg 87(3):225–232 CrossRefPubMed
13.
Zurück zum Zitat Muratore A, Mellano A, Marsanic P, De Simone M (2015) Transanal total mesorectal excision (taTME) for cancer located in the lower rectum: short- and mid-term results. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical. Oncology 41(4):478–483 Muratore A, Mellano A, Marsanic P, De Simone M (2015) Transanal total mesorectal excision (taTME) for cancer located in the lower rectum: short- and mid-term results. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical. Oncology 41(4):478–483
14.
Zurück zum Zitat Tuech JJ, Karoui M, Lelong B, De Chaisemartin C, Bridoux V, Manceau G et al (2015) A step toward NOTES total mesorectal excision for rectal cancer: endoscopic transanal proctectomy. Ann Surg 261(2):228–233 CrossRefPubMed Tuech JJ, Karoui M, Lelong B, De Chaisemartin C, Bridoux V, Manceau G et al (2015) A step toward NOTES total mesorectal excision for rectal cancer: endoscopic transanal proctectomy. Ann Surg 261(2):228–233 CrossRefPubMed
15.
Zurück zum Zitat Kneist W, Hanke L, Kauff DW, Lang H (2016) Surgeons’ assessment of internal anal sphincter nerve supply during TaTME—inbetween expectations and reality. Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive. Therapy 25(5):241–246 Kneist W, Hanke L, Kauff DW, Lang H (2016) Surgeons’ assessment of internal anal sphincter nerve supply during TaTME—inbetween expectations and reality. Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive. Therapy 25(5):241–246
16.
Zurück zum Zitat Rink AD, Kneist W (2019) How to Report on Distal Resection Margins in Trials on Rectal Cancer Surgery. Dis Colon Rectum 62(1):e1–e2 CrossRefPubMed Rink AD, Kneist W (2019) How to Report on Distal Resection Margins in Trials on Rectal Cancer Surgery. Dis Colon Rectum 62(1):e1–e2 CrossRefPubMed
17.
Zurück zum Zitat Rosen HR Kneist W, Fürst A, Krämer G, Hebenstreit J, Schiemer JF (2019) Randomized clinical trial of prophylactic transanal irrigation versus supportive therapy to prevent symptoms of low anterior resection syndrome after rectal resection. Br J Surg open. https://​doi.​org/​10.​1002/​bjs5.​50160 Rosen HR Kneist W, Fürst A, Krämer G, Hebenstreit J, Schiemer JF (2019) Randomized clinical trial of prophylactic transanal irrigation versus supportive therapy to prevent symptoms of low anterior resection syndrome after rectal resection. Br J Surg open. https://​doi.​org/​10.​1002/​bjs5.​50160
18.
Zurück zum Zitat Adamina M, Buchs NC, Penna M, Hompes R (2018) St.Gallen Colorectal Consensus Expert G. St.Gallen consensus on safe implementation of transanal total mesorectal excision. Surg Endosc 32(3):1091–1103 CrossRefPubMed Adamina M, Buchs NC, Penna M, Hompes R (2018) St.Gallen Colorectal Consensus Expert G. St.Gallen consensus on safe implementation of transanal total mesorectal excision. Surg Endosc 32(3):1091–1103 CrossRefPubMed
19.
Zurück zum Zitat Kneist W, Aigner F, Fürst A, Wedel T (2017) Urethral injury in body donor TaTME training. Coloproctology 39(3):179–183 CrossRef Kneist W, Aigner F, Fürst A, Wedel T (2017) Urethral injury in body donor TaTME training. Coloproctology 39(3):179–183 CrossRef
20.
Zurück zum Zitat Aigner F, Biebl M, Furst A, Jons T, Pratschke J, Kneist W (2017) Training course transanal total mesorectal excision (TaTME) : Concept and establishment of a training course for safe application. Chirurg 88(2):147–154 CrossRefPubMed Aigner F, Biebl M, Furst A, Jons T, Pratschke J, Kneist W (2017) Training course transanal total mesorectal excision (TaTME) : Concept and establishment of a training course for safe application. Chirurg 88(2):147–154 CrossRefPubMed
Metadaten
Titel
Transanale totale mesorektale Exzision
Eine sinnvolle Komplementärmethode zur minimal-invasiven Operation des Rektumkarzinoms
verfasst von
PD Dr. A. D. Rink
F. Aigner
M. Biebl
A. Fürst
W. Kneist
Publikationsdatum
07.05.2019
Verlag
Springer Medizin
Erschienen in
Die Chirurgie / Ausgabe 6/2019
Print ISSN: 2731-6971
Elektronische ISSN: 2731-698X
DOI
https://doi.org/10.1007/s00104-019-0967-4

Weitere Artikel der Ausgabe 6/2019

Die Chirurgie 6/2019 Zur Ausgabe

Passend zum Thema

ANZEIGE

Magenkarzinom: Experten geben Handlungsempfehlungen

Die Sequenztherapie beim metastasierten Adenokarzinom des Magens und des gastroösophagealen Übergangs (AEG) spielt eine immer größere Rolle. Speziell für die ideale Integration einer Taxan-haltigen Behandlung im Therapiealgorithmus stellen sich Fragen: Ein Expertenkonsens gibt konkrete Handlungsempfehlungen für den Praxisalltag.

ANZEIGE

Zwischen Trend & Kausalität: Kaffee & Überleben

4 und mehr Tassen Kaffee am Tag können das Sterberisiko bei Patienten mit mCRC um 36 % senken – verglichen mit Kaffee-Abstinenzlern. Dies und Weiteres deutet eine kürzlich in JAMA veröffentlichte Studie an. Was bringt Kaffee bei Darmkrebs und wie macht er das?

ANZEIGE

GI-Tumore und die Rolle von Angiogenesehemmern

Entdecken Sie mit praxisrelevanten Patientenfällen, kompakten Studieninhalten, informativen Experteninterviews und weiteren spannenden Inhalte, wie Sie den vielseitigen Herausforderungen bei GI-Tumoren begegnen können. Hier erfahren Sie mehr!